title: Secondary intracranial hypertension from testosterone therapy in a transgender patient.
abstract: We report an occurrence of intracranial hypertension secondary to testosterone therapy in a transgender patient. This is the first reported case to our knowledge demonstrating a direct association with raised levels of free testosterone and intracranial hypertension.
authors.affiliation: The Tennent Institute of Ophthalmology, Gartnavel General Hospital , Glasgow , UK and.
authors.forename: Soo
authors.initials: S
authors.lastname: Park
authors.forename: Chee Peng
authors.initials: CP
authors.lastname: Cheng
authors.forename: Lik Thai
authors.initials: LT
authors.lastname: Lim
authors.forename: David
authors.initials: D
authors.lastname: Gerber
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use; D000284:Administration, Oral; D000728:Androgens / Q000009:adverse effects*; D001794:Blood Pressure; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D015170:Cerebrospinal Fluid Pressure; D006801:Humans; D007273:Injections, Intramuscular; D019586:Intracranial Hypertension / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D010211:Papilledema / Q000139:chemically induced; D013739:Testosterone / Q000097:blood; D043343:Testosterone Propionate / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D063106:Transgender Persons; D014792:Visual Acuity / Q000502:physiology; D055815:Young Adult; D005260:Female
chemical_list: D000728:Androgens; D002257:Carbonic Anhydrase Inhibitors; D013739:Testosterone; D000086:Acetazolamide; D043343:Testosterone Propionate